PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9362376-1	1997	Recently, we developed a series of cluster mannosides that were able to inhibit tissue-type plasminogen activator (t-PA) binding to the isolated mannose receptor.	Mannosides	43-53	plasminogen activator, tissue type	Homo sapiens	80-113	
9362376-7	1997	The concentrations of mannoside necessary to inhibit 125I-t-PA degradation in vitro were comparable with the concentrations necessary to inhibit mannose receptor-mediated 125I-t-PA clearance in vivo.	Mannosides	22-31	plasminogen activator, tissue type	Homo sapiens	58-62	
9362376-1	1997	Recently, we developed a series of cluster mannosides that were able to inhibit tissue-type plasminogen activator (t-PA) binding to the isolated mannose receptor.	Mannosides	43-53	plasminogen activator, tissue type	Homo sapiens	115-119	
9362376-3	1997	To test whether these mannosides would also be efficient inhibitors in humans, we studied the expression of the mannose receptor in the human liver and determined the efficacy of the mannosides to inhibit mannose receptor-mediated t-PA degradation by both rat and human cells.	Mannosides	22-32	plasminogen activator, tissue type	Homo sapiens	231-235	
9362376-3	1997	To test whether these mannosides would also be efficient inhibitors in humans, we studied the expression of the mannose receptor in the human liver and determined the efficacy of the mannosides to inhibit mannose receptor-mediated t-PA degradation by both rat and human cells.	Mannosides	183-193	plasminogen activator, tissue type	Homo sapiens	231-235	
9362376-6	1997	The cluster mannoside with six mannose residues connected with a backbone of five lysine groups (M6L5) was, like unlabeled t-PA, able to inhibit 125I-t-PA degradation in the nmol/L range, while the mannoside M5L4 inhibited 125I-t-PA degradation in the micromol/L range.	Mannosides	12-21	plasminogen activator, tissue type	Homo sapiens	123-127	
9362376-6	1997	The cluster mannoside with six mannose residues connected with a backbone of five lysine groups (M6L5) was, like unlabeled t-PA, able to inhibit 125I-t-PA degradation in the nmol/L range, while the mannoside M5L4 inhibited 125I-t-PA degradation in the micromol/L range.	Mannosides	12-21	plasminogen activator, tissue type	Homo sapiens	150-154	
9362376-6	1997	The cluster mannoside with six mannose residues connected with a backbone of five lysine groups (M6L5) was, like unlabeled t-PA, able to inhibit 125I-t-PA degradation in the nmol/L range, while the mannoside M5L4 inhibited 125I-t-PA degradation in the micromol/L range.	Mannosides	12-21	plasminogen activator, tissue type	Homo sapiens	150-154